Response-Guided Neoadjuvant Sacituzumab Govitecan Therapy for Localized TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial
Ann. Oncol 2024 Mar 01;35(3)293-301, LM Spring, SM Tolaney, G Fell, V Bossuyt, RO Abelman, B Wu, S Maheswaran, L Trippa, A Comander, T Mulvey, S McLaughlin, P Ryan, L Ryan, E Abraham, A Rosenstock, AC Garrido-Castro, F Lynce, B Moy, SJ Isakoff, N Tung, EA Mittendorf, LW Ellisen, A BardiaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.